According to our latest research, the global Idursulfase market size reached USD 1.30 billion in 2025, demonstrating robust growth in the rare disease therapeutics sector. The market is expected to expand at a CAGR of 7.4% during the forecast period, reaching a projected value of USD 2.45 billion by 2034. This growth is primarily driven by increasing awareness, improved diagnostic capabilities, and the ongoing development of orphan drugs for rare genetic disorders. The upward trajectory of the Idursulfase market is further supported by advancements in biotechnology and a growing focus on personalized medicine for lysosomal storage disorders. The broader enzyme replacement therapy landscape continues to expand rapidly, providing a strong tailwind for Idursulfase demand through the forecast horizon. https://growthmarketreports.com/report/idursulfase-market